BSE filing, NSE: DABUR. Summary written from the filing by ALFA Finder's alert engine.
Dabur India Ltd: key numbers
- Share price
- ₹360.00
- Market cap
- ₹63,862 Cr
- Revenue (annual)
- ₹13,193 Cr
- Net profit (annual)
- ₹1,895 Cr
- P/E (TTM)
- 32.4×Sector 38.3×
- Promoter holding
- 66.25%+0.01% QoQ
- FII holding
- 9.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dabur India Ltd
All →Dabur India Other Announcement
Dabur India Ltd filed its quarterly shareholding pattern as of September 30, 2026, noting changes in promoter entities due to mergers and corporate actions.
Dabur India Debt & Borrowing: ₹250 Cr
Dabur India submitted a periodic disclosure for its Rs. 250 Crore Unsecured Non-Convertible Debentures, confirming the outstanding status as of September 2026.
- Value
- ₹250.0 Cr
Dabur India Other Announcement
Dabur India has filed the mandatory Regulation 74(5) certificate from its Registrar, KFin Technologies, for the quarter ended September 30, 2026.
Dabur India Business Update
Dabur issued a pre-results Q2 FY27 demand update expecting double-digit consolidated revenue and PAT growth. Segment-level qualitative growth bands are provided without specific rupee figures.
Dabur India Acquisition
Dabur India Limited received NCLT approval for the merger of Sesa Care Private Limited into the company. This integration strengthens Dabur's Ayurvedic hair care portfolio following an initial 51% CRPS acquisition.
Dabur India Board Meeting Date
Dabur India announced a board meeting on 04 Nov 2026 to consider Q1 FY27 unaudited results and interim dividend. No financial figures are disclosed in this advance notice.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date